BioLineRx Ltd. Holds Annual Shareholder Meeting
Ticker: BLRX · Form: 6-K · Filed: Jun 30, 2025 · CIK: 1498403
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance, annual-report
TL;DR
BioLineRx held its shareholder meeting on June 29, 2025, results to follow.
AI Summary
BioLineRx Ltd. announced the results of its Annual General Meeting of Shareholders held on June 29, 2025. The meeting took place at 3:00 p.m. Israel time, and shareholders voted on various matters presented by the company.
Why It Matters
Shareholder meetings are crucial for corporate governance, allowing investors to influence company direction and hold management accountable.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a shareholder meeting's results and does not contain significant financial or operational changes.
Key Players & Entities
- BioLineRx Ltd. (company) — Registrant
- June 29, 2025 (date) — Date of Annual General Meeting
FAQ
What was the purpose of the Annual General Meeting of Shareholders for BioLineRx Ltd. on June 29, 2025?
The purpose was to announce the results of the meeting where shareholders voted on matters presented by the company.
When and where was the BioLineRx Ltd. Annual General Meeting held?
The meeting was held on June 29, 2025, at 3:00 p.m. Israel time.
What form does BioLineRx Ltd. file its annual reports under?
BioLineRx Ltd. files its annual reports under Form 20-F.
What is the principal executive office address for BioLineRx Ltd.?
The principal executive offices are located at 2 HaMa'ayan Street, Modi'in 7177871, Israel.
Is BioLineRx Ltd. a foreign private issuer?
Yes, the filing is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 30, 2025 regarding BioLineRx Ltd. (BLRX).